Views of Nurses on Alarm Fatigue in ICUs

July 7, 2022 updated by: Fatma CEBECİ, Akdeniz University

Nurses' Views on Alarm Fatigue and Its Reduction in Adult Intensive Care Units: Convergent Parallel Design

This study focused on determining the views of nurses on alarm fatigue and its reduction in adult intensive care units.

Study Overview

Status

Completed

Conditions

Detailed Description

Backround: Physiological monitoring of critically ill patients in ICU is a complex nursing task, and nurses are key professionals managing multiple monitoring devices.

Aim: The aim of this study is to determine the views of nurses on alarm fatigue and its prevention in adult intensive care units.

Study Design: In the study, the minimum sample size was calculated as 67 for a population size of 106 and a 95% confidence interval, taking into account the alarm fatigue standard deviation (σ=6.82) found in the Turkish validity study of the "Nurses' Alarm Fatigue Scale" (t=1.96; d=1) . Considering that there may be losses, 74 nurses will be included in the study by taking 10% more. In the qualitative phase of the research, intensive care nurses who agreed to be interviewed during the collection of quantitative data will be included.

Method: In this study, parallel data type will be used in convergent parallel mixed design. The quantitative phase of the study is a descriptive study to determine alarm fatigue levels in nurses working in adult intensive care units. In the qualitative phase of the research; A case study will be conducted at the same time in order to examine the findings revealed with quantitative data in more depth and to determine the views of nurses on reducing alarm fatigue. Individual in-depth interviews will be held in a suitable room using the "Semi-Structured Interview Form" created by the researchers with those who agree to participate in the qualitative study.

Study Type

Observational

Enrollment (Actual)

67

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Antalya, Turkey, 07058
        • Akdeniz University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

The research populations consists of nurses working in adult ICU a University Hospital. The sample number was calculated with the formula known population and the cases average of the event in the study. In this study, considering the alarm fatigue standard deviation (σ=6.82) found in the Turkish validity study of the scale, the minimum sample size was calculated as 67 for a population size of 106 and a 95% confidence interval (t=1.96; d=1). Considering that there may be losses 10% more (74 nurses) will be taken.

The qualitative phase of the research will be with nurses who agreed to be interview and will be terminated when the data reach the saturation point and no new information emerge.

Description

Inclusion Criteria:

  • 18 years and older
  • Who volunteered to participate in the research
  • Working in adult intensive care units

Exclusion Criteria:

  • Under the age of 18
  • Not working in adult intensive care unit

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nurses' Alarm Fatigue Scale
Time Frame: 30 May 2022
The scale consists of 9 items and the score range is between 0-36. High scores indicate the effects of alarm fatigue on nurses' performance. Each item in the questionnaire is scored between 0 and 4.
30 May 2022

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 6, 2022

Primary Completion (ACTUAL)

June 30, 2022

Study Completion (ACTUAL)

June 30, 2022

Study Registration Dates

First Submitted

December 6, 2021

First Submitted That Met QC Criteria

December 17, 2021

First Posted (ACTUAL)

December 20, 2021

Study Record Updates

Last Update Posted (ACTUAL)

July 8, 2022

Last Update Submitted That Met QC Criteria

July 7, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KAEK-271

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nurse's Role

3
Subscribe